酵素は,その反応する断片を抑制することで,実際にどれだけの利益を得ているのでしょうか
1Department of Chemistry, University of Southern California, Los Angeles, California 90089-1062, USA.
Journal of the American Chemical Society
|April 11, 2002
まとめ
ステリック効果は酵素触媒の主要な原動力ではない. コンピュータシミュレーションでは,ステリック力ではなく,静電相互作用が,ハロアルカン脱ハロゲナースの鍵であることを明らかにしています.
科学分野:
- バイオケミストリー バイオケミストリー
- コンピューティング・ケミストリー
- 酵素触媒は,酵素触媒として作用する.
背景:
- 酵素触媒はしばしばステリック効果に起因し,基質を接近攻撃構成 (NAC) に押し込む.
- 酵素触媒におけるステリック貢献と静電力の役割は,依然として研究対象である.
- ハロアルカン脱ハロゲナーゼは,触媒機構の研究のためのモデル酵素として機能します.
研究 の 目的:
- コンピュータシミュレーションを使用して,酵素触媒におけるステリック効果の相対的重要性を定量的に評価する.
- ハロアルカン脱ハロゲナーゼの触媒力に対するステリックと静電の貢献を区別する.
主な方法:
- 実験的なバレンスの結合 (EVB) 方法を使用して,反応電位面をモデル化しました.
- 水中の反応と酵素反応を比較するために熱力学サイクルを使用した.
- 2つの計算戦略を開発した:水中の基板の制限と静電相互作用の排除.
主要な成果:
- 触媒への非静電的 (ステリック) 貢献は,約 -0.7 kcal/mol.であることが判明しました.
- 静電的貢献を含む明らかなステリック効果は -2.2 kcal/molでした.
- 電気静的相互作用が触媒効果の大部分を占め,約 -6.1 kcal/molであった.
結論:
- ステリック効果は,ハロアルカン脱ハロゲナーゼにおける触媒力の主要な源ではありません.
- 静電相互作用は,酵素の触媒効率に支配的な役割を果たします.
- 明らかにステリックな効果は,溶媒の再編成エネルギーによって大きく影響され,従来の見解に異議を唱える.
さらに関連する動画
関連する概念動画
Feedback Inhibition
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Enzymes
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Restriction Enzymes
Restriction enzymes are bacterial enzymes used to cut DNA in a sequence-specific manner. To cleave DNA, they bind to specific palindromic sequences called restriction sites. Such palindromic DNA sequences or inverted repeats are commonly found in regions of functional significance, such as the origin of replication, gene operator sites, and regions containing transcription termination signals.
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...


